Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma

被引:63
|
作者
Young, Jonathan R. [1 ]
Coy, Heidi [1 ]
Kim, Hyun J. [1 ]
Douek, Michael [1 ]
Lo, Pechin [1 ]
Pantuck, Allan J. [2 ]
Raman, Steven S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 757 Westwood Plaza,Ste 1638, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
MRI; multiphasic; oncocytoma; renal cell carcinoma; PATHOLOGICAL FINDINGS; HISTOLOGIC SUBTYPES; HELICAL CT; TUMORS; CLASSIFICATION; NEOPLASMS; PARAMETERS; FEATURES; DISEASE; SYSTEM;
D O I
10.2214/AJR.16.17152
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma. MATERIALS AND METHODS. For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e., unenhanced, corticomedullary, nephrographic, excretory) from 2005 to 2016. These groups were evaluated for multiphasic enhancement and were compared using Kruskal-Wallis and Mann-Whitney tests. ROC curves were constructed and logistic regression analyses were performed to evaluate the performance of multiphasic enhancement in differentiating clear cell RCCs from the other three groups. RESULTS. Clear cell RCCs exhibited significantly greater relative signal intensity compared with uninvolved renal cortex in the corticomedullary phase (mean, 2.9) than oncocytomas (-21.7, p = 0.001), papillary RCCs (-53.0, p < 0.001), and chromophobe RCCs (-21.0, p < 0.001). Relative signal intensity in the corticomedullary phase differentiated clear cell RCCs from oncocytomas with an AUC of 0.90 and with an accuracy of 84% (32/38), sensitivity of 90% (27/30), and specificity of 63% (5/8) after controlling for lesion size, patient age, and patient sex. Relative corticomedullary signal intensity differentiated clear cell RCCs from oncocytomas and other RCC subtypes with an AUC of 0.93 and with an accuracy of 90% (53/59), sensitivity of 90% (27/30), and specificity of 90% (26/29) after controlling for lesion size, patient age, and patient sex. CONCLUSION. Multiphasic MRI enhancement may assist in differentiating clear cell RCC from oncocytomas and other RCC subtypes, if validated in prospective studies.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [31] Expression of MAP kinase and Akt in clear renal cell carcinoma (RCC), including sarcomatoid RCC
    Tamboli, P
    Mathew, P
    Bekele, BN
    Prieto, VG
    LABORATORY INVESTIGATION, 2005, 85 : 166A - 166A
  • [32] Expression of MAP kinase and akt in clear renal cell carcinoma (RCC), including sarcomatoid RCC
    Tamboli, P
    Mathew, P
    Bekele, BN
    Prieto, VG
    MODERN PATHOLOGY, 2005, 18 : 166A - 166A
  • [33] Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes
    Fisel, Pascale
    Buettner, Florian
    Reustle, Anna
    Klumpp, Verena
    Winter, Stefan
    Rausch, Steffen
    Hennenlotter, Joerg
    Kruck, Stephan
    Stenzl, Arnulf
    Wahrheit, Judith
    Sonntag, Denise
    Scharpf, Marcus
    Fend, Falko
    Agaimy, Abbas
    Hartmann, Arndt
    Bedke, Jens
    Schwab, Matthias
    Schaeffeler, Elke
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Renal Cell Carcinomas With Mixed Histologic Patterns Resembling Both Clear Cell RCC (CCRCC) and Clear Cell Papillary RCC (CCPRCC): Analysis of 39 Cases
    Dhakal, Hari
    McKenney, Jesse
    Reynolds, Jordan
    Magi-Galluzzi, Cristina
    Przybycin, Christopher
    MODERN PATHOLOGY, 2015, 28 : 215A - 215A
  • [35] Renal Cell Carcinomas With Mixed Histologic Patterns Resembling Both Clear Cell RCC (CCRCC) and Clear Cell Papillary RCC (CCPRCC): Analysis of 39 Cases
    Dhakal, Hari
    McKenney, Jesse
    Reynolds, Jordan
    Magi-Galluzzi, Cristina
    Przybycin, Christopher
    LABORATORY INVESTIGATION, 2015, 95 : 215A - 215A
  • [36] Re: Differentiation of Papillary Renal Cell Carcinoma Subtypes on CT and MRI
    Siegel, Cary
    JOURNAL OF UROLOGY, 2014, 191 (03): : 627 - 627
  • [37] Recently proposed oncocytic variant of chromophobe renal cell carcinoma (RCC) expressing BSND and ATP6V1G3: two new immunohistochemical markers differentiating chromophobe RCC from other RCC subtypes
    Tajima, Shogo
    Mori, Yoichi
    Mukaiyama, Yoshihiro
    Shinmura, Kazuya
    Koda, Kenji
    Kuroda, Naoto
    Hayami, Shinsuke
    Homma, Yukio
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2374 - 2381
  • [38] PAX8 Expression in Clear Cell, Papillary and Chromphobe RCC and Urothelial Carcinoma of Renal Pelvis
    Jadallah, S.
    Albadine, R.
    Sharma, R.
    Netto, G. J.
    MODERN PATHOLOGY, 2009, 22 : 174A - 174A
  • [39] CAD-based discrimination of clear cell renal cell carcinoma from RCC subtypes and benign small renal masses at multidector CT
    Coy, Heidi
    Young, Jonathan
    Douek, Michael
    Ko, Moe Moe
    Ko, War War
    Lo, Pechin
    Brown, Matthew S.
    Goldin, Jonathan
    Raman, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Separation of chromophobe renal cell carcinoma from oncocytoma and clear cell carcinoma: An optimal immunohistochemical panel for differential diagnosis
    Liu, LN
    Bostwick, DG
    Qian, JQ
    Meiers, I
    Singh, H
    Tops, TL
    Zhou, XG
    JOURNAL OF UROLOGY, 2006, 175 (04): : 350 - 350